Generic Name and Formulations:
Phenylephrine 1%, ketorolac 0.3%; oph soln for inj after dilution.
Indications for OMIDRIA:
To maintain pupil size by preventing intraoperative miosis and reducing post-op ocular pain. During cataract surgery or intraocular lens replacement, when added to an ophthalmic irrigation solution.
≥18yrs: dilute 4mL of solution in 500mL of ophthalmic irrigation solution. Use as needed for surgical procedure.
<18yrs: not established.
May elevate blood pressure. Aspirin or NSAID sensitivity. History of asthma. Pregnancy (Cat.C); avoid in 3rd trimester. Nursing mothers.
Alpha-1 agonist + NSAID.
Eye irritation, posterior capsule opacification, increased intraocular pressure, anterior chamber inflammation.
Single-use vials (4mL)—4, 10
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments
- Increase Use of Nursing Home for Patients With Cognitive Impairment Category
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder